FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026
FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026
A brief intake will confirm the practice type, address Rx handling in accordance with FDA compliance, and review the scope related to the Drug Supply Chain Act (DSCSA) for RX and pharmaceutical drugs.
Off-site review of vendor records, purchasing data, and operational documentation is essential for ensuring compliance with the Drug Supply Chain Act (DSCSA) and meeting FDA compliance standards, especially in the context of a Medical Audit involving RX and Pharmaceutical Drugs.
Clear identification of exposure areas tied to current enforcement behavior related to the Drug Supply Chain Act (DSCSA) is crucial for ensuring FDA compliance in the handling of RX and pharmaceutical drugs, particularly during a medical audit.
We provide prioritized, actionable recommendations that align with inspection expectations, ensuring compliance with the Drug Supply Chain Act (DSCSA) and FDA compliance requirements for RX and pharmaceutical drugs during a medical audit.

Confirm practice type, Rx handling activities, and review scope.
Review vendor records, purchasing data, and operational documentation off-site.
Identify exposure areas tied to inspection and documentation expectations.
Provide prioritized, actionable recommendations aligned to enforcement behavior.
Copyright © 2026 claritasaxis.com - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.